Takeda Y, Honda T, Miwatani T
Dev Biol Stand. 1983;53:113-21.
For identification of enterotoxigenic Escherichia coli producing heat labile enterotoxin (LT), various assay methods have been developed. However, many of these assay methods are unsuitable for routine clinical purposes, especially in developing countries, because they need special materials or techniques or both, such as a large number of animals, stocks of special tissue culture cells, and radioisotopes. Recently, we developed a simple and reproducible assay method, Biken test, which can be widely used in clinical laboratories in both developing and developed countries (15). This method is based on the principles of the Elek test and Ouchterlony double gel diffusion test. The Biken test was used in a field study in Bangladesh with good results (14). Moreover, the Diarrheal Diseases Control Programme, WHO, organized a multi-laboratory study to evaluate the accuracy and reproducibility of the Biken test, in which 5 investigators tested an identical set of 100 unknown strains of E. coli, using the Biken test and at least one other assay method, which includes CHO cell assay, Y1 adrenal cell assay, GM1 ganglioside ELISA, DNA probe test and passive immune hemolysis. The results reported by Sutton (International Symposium on Bacterial Diarrheal Diseases, Osaka, 1982) showed that the Biken test was a reliable assay method. To evaluate further the Biken test, we tested a total of 2,229 strains of E. coli isolated from diarrheal patients. The results showed 99.0% coincidence with those obtained by CHO cell assay. The use of anti-LT antiserum gave sharper and clearer results than cholera antitoxin. Samples for heat stable enterotoxin (ST) assay were obtained from the agar plates used for the Biken test and the ST activities of these samples were compared with those of samples obtained from standard liquid cultures. Results on samples of 2,229 strains from the Biken agar plates and from liquid cultures were almost identical.
为鉴定产热不稳定肠毒素(LT)的产肠毒素性大肠杆菌,已开发出多种检测方法。然而,这些检测方法中的许多都不适用于常规临床目的,尤其是在发展中国家,因为它们需要特殊材料或技术或两者兼备,例如大量动物、特殊组织培养细胞株和放射性同位素。最近,我们开发了一种简单且可重复的检测方法——比肯试验,该方法可在发展中国家和发达国家的临床实验室中广泛使用(15)。此方法基于埃lek试验和奥克特洛尼双向凝胶扩散试验的原理。比肯试验在孟加拉国的一项现场研究中使用,结果良好(14)。此外,世界卫生组织腹泻病控制规划组织了一项多实验室研究,以评估比肯试验的准确性和可重复性,其中5名研究人员使用比肯试验和至少一种其他检测方法,包括CHO细胞试验、Y1肾上腺细胞试验、GM1神经节苷脂酶联免疫吸附测定、DNA探针试验和被动免疫溶血,对一组相同的100株未知大肠杆菌菌株进行检测。萨顿(1982年大阪细菌性腹泻病国际研讨会)报告结果表明,比肯试验是一种可靠的检测方法。为进一步评估比肯试验,我们共检测了从腹泻患者分离出的2229株大肠杆菌菌株。结果显示与CHO细胞试验结果的一致性为99.0%。使用抗LT抗血清比霍乱抗毒素产生的结果更清晰、更明确。用于热稳定肠毒素(ST)检测的样本取自比肯试验所用的琼脂平板,并将这些样本的ST活性与从标准液体培养物中获得的样本进行比较。来自比肯琼脂平板和液体培养物的2229株菌株样本的结果几乎相同。